CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash Flows from Operating Activities
Net loss	$ (19,492,172)	$ (1,761,156)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	989,116	326,204
Impairment of goodwill		3,648,000
Deferred income tax benefit		(12,190,693)
Interest paid on the conversion of debt to equity	21,275
Common stock issued in exchange for services rendered	6,425
Common stock issued in Napo merger for services		151,351
Loss on extinguishment of debt		207,713
Charge in relation to modification of warrants		23,000
Stock-based compensation	1,416,791	630,924
Amortization of debt issuance costs and debt discount	1,461,133	367,891
Change in fair value of warrants, conversion option and derivative liability	(178,461)	(637,121)
Changes in assets and liabilities
Accounts receivable	(561,012)	(457,576)
Other receivable	(175,009)	(17,349)
Inventory	(477,217)	369,155
Prepaid expenses and other current assets	(635,622)	(256,057)
Deferred offering costs	(1,255,554)	(231,253)
Other non-current assets	(289,828)	122,163
Due from former parent		(164,647)
Deferred revenue	(177,389)	814,589
Deferred product revenue		(6)
Deferred rent	52,665	(1,028)
Accounts payable	(904,577)	4,691,363
Accrued expenses	2,370,682	(130,255)
Total cash used in operations	(17,828,754)	(4,494,788)
Cash Flows from Investing Activities
Purchase of equipment	(6,527)
Cash paid in Napo merger, net of cash acquired		(1,557,340)
Change in restricted cash		11,293
Total cash used in investing activities	(6,527)	(1,546,047)
Cash Flows from Financing Activities
Proceeds from issuance of long-term debt	2,310,000
Payments of long-term debt	(1,689,200)	(2,161,262)
Proceeds from issuance of convertible debt	500,000	1,700,000
Proceeds from the issuance of common stock through the exercise of common stock warrants		363,334
Proceeds from the issuance of convertible preferred stock net of issuance costs	9,000,002
Fractional common stock shares repurchased	(30)
Total Cash Provided by Financing Activities	17,801,543	5,310,446
Net decrease in cash and cash equivalents	(33,738)	(730,389)
Cash and restricted cash at beginning of period	759,867	950,979
Cash and restricted cash at end of period	726,129	220,590
Supplemental Schedule of Non-Cash Financing and Investing Activities
Interest paid on long-term debt	19,344	201,835
Deemed dividend attributable to preferred stock	995,000
Fair value of common stock issued in a merger		25,303,859
Fair value of replacement of common stock warrants issued in a merger		630,859
Fair value of replacement restricted stock units issued in a merger		3,300,555
Fair value of replacement stock options issued in a merger		5,691
September 2018 L2 convertible note payable
Supplemental Schedule of Non-Cash Financing and Investing Activities
Common stock issued with September 2018 Promissory Notes	$ 48,000
Warrants issued with the September 2018 Promissory Notes	118,148
Private Investment in Public Entities June 2016
Cash Flows from Financing Activities
Proceeds from issuance of common stock		2,314,374
Issuance costs associated with the issuance of common stock in a private investment in public entities		61,781
Private Investment in Public Entities June 2017
Cash Flows from Financing Activities
Proceeds from issuance of common stock		94,000
Issuance costs associated with the issuance of common stock in a private investment in public entities		6,000
Private Investment in Public Entities July 2017
Cash Flows from Financing Activities
Proceeds from issuance of common stock		$ 3,000,000
Private investment in public entities with new investors
Cash Flows from Financing Activities
Proceeds from the issuance of common stock through a stock purchase agreement	$ 1,305,774
Private investment in public entities with existing investors
Cash Flows from Financing Activities
Proceeds from issuance of common stock	750,100
Private Investment in Public Entities March 2018
Cash Flows from Financing Activities
Proceeds from issuance of common stock	5,000,000
Private Investment in Public Entities July 2018
Cash Flows from Financing Activities
Proceeds from issuance of common stock	624,897
Jaguar Notes Payable
Supplemental Schedule of Non-Cash Financing and Investing Activities
Common stock issued as redemption of notes payable and related interest	1,153,408
Napo convertible notes
Supplemental Schedule of Non-Cash Financing and Investing Activities
Common stock issued as redemption of notes payable and related interest	$ 1,638,546